|
Mutation Information
|
Mutation Site
|
F519S |
|
Mutation Type
|
Amino acid level |
|
Gene/Protein/Region Type
|
Env |
Literature Information
|
PubMed PMID
|
32748788
|
|
Published Year
|
2020 |
|
Journal
|
eLife |
|
Title
|
Tailored design of protein nanoparticle scaffolds for multivalent presentation of viral glycoprotein antigens. |
|
Author
|
Ueda G,Antanasijevic A,Fallas JA,Sheffler W,Copps J,Ellis D,Hutchinson GB,Moyer A,Yasmeen A,Tsybovsky Y,Park YJ,Bick MJ,Sankaran B,Gillespie RA,Brouwer PJ,Zwart PH,Veesler D,Kanekiyo M,Graham BS,Sanders RW,Moore JP,Klasse PJ,Ward AB,King NP,Baker D |
|
Evidence
|
BG505 SOSIP variant used for all early optimizations steps was engineered with a combination of v5.2 (mutations: E64K, A73C, A316W, A561C) and MD3D (mutations: M271I, A318Y, R585H, L568D, V570H, R304V, F519S) stabilizing mutations, and had glycosylation sites introduced at positions 241 and 289 (mutations: P240T, S241N, F288L, T290E, P291S).
|
|
|
HIV Mutation Detail Information